Verastem reported $20.09M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
AstraZeneca AZN:LN 1791796.84M 60282.28M
Curis CRIS:US $ 12.15M 2.46M
Cytokinetics CYTK:US $ 66.84M 0M
Epizyme EPZM:US $ 34.95M 4.01M
Gilead Sciences GILD:US $ 9220M 662M
Immunogen IMGN:US $ 87.07M 2.95M
Laboratory Of America LH:US $ 2642.9M 1.4M
Novartis NOVN:VX SF 27646M 2161M
Verastem VSTM:US $ 20.09M 3.21M
YTE INCY:US $ 926.67M 40.51M
Ziopharm Oncology ZIOP:US $ 26.78M 5.54M